Invention Grant
- Patent Title: Self-crosslinking antibodies
-
Application No.: US16068892Application Date: 2017-01-09
-
Publication No.: US11459397B2Publication Date: 2022-10-04
- Inventor: Calin Dumitru , Elisabeth M. Gardiner , Robert P. Mckenzie , Michael H. Matho
- Applicant: Meditope Biosciences, Inc.
- Applicant Address: US CA Pasadena
- Assignee: Meditope Biosciences, Inc.
- Current Assignee: Meditope Biosciences, Inc.
- Current Assignee Address: US CA Pasadena
- Agency: Adriano & Associates
- International Application: PCT/US2017/012754 WO 20170109
- International Announcement: WO2017/120599 WO 20170713
- Main IPC: C07K16/32
- IPC: C07K16/32 ; C07K16/00 ; C07K7/00 ; C07K16/28 ; C07K16/30 ; A61P35/00
Abstract:
Provided are self-crosslinking meditope-enabled antibodies. Also provided are methods for altering the distribution of a cell surface antigen using self-crosslinking meditope enabled antibodies, compositions for use in the methods, and methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses.
Public/Granted literature
- US20190016822A1 SELF-CROSSLINKING ANTIBODIES Public/Granted day:2019-01-17
Information query
